Literature DB >> 17314156

Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections.

Christine M Rousseau1, Gerald H Learn, Tanmoy Bhattacharya, David C Nickle, David Heckerman, Senica Chetty, Christian Brander, Philip J R Goulder, Bruce D Walker, Photini Kiepiela, Bette T Korber, James I Mullins.   

Abstract

Recombinant human immunodeficiency virus type 1 (HIV-1) strains containing sequences from different viral genetic subtypes (intersubtype) and different lineages from within the same subtype (intrasubtype) have been observed. A consequence of recombination can be the distortion of the phylogenetic signal. Several intersubtype recombinants have been identified; however, less is known about the frequency of intrasubtype recombination. For this study, near-full-length HIV-1 subtype C genomes from 270 individuals were evaluated for the presence of intrasubtype recombination. A sliding window schema (window, 2 kb; step, 385 bp) was used to partition the aligned sequences. The Shimodaira-Hasegawa test detected significant topological incongruence in 99.6% of the comparisons of the maximum-likelihood trees generated from each sequence partition, a result that could be explained by recombination. Using RECOMBINE, we detected significant levels of recombination using five random subsets of the sequences. With a set of 23 topologically consistent sequences used as references, bootscanning followed by the interactive informative site test defined recombination breakpoints. Using two multiple-comparison correction methods, 47% of the sequences showed significant evidence of recombination in both analyses. Estimated evolutionary rates were revised from 0.51%/year (95% confidence interval [CI], 0.39 to 0.53%) with all sequences to 0.46%/year (95% CI, 0.38 to 0.48%) with the putative recombinants removed. The timing of the subtype C epidemic origin was revised from 1961 (95% CI, 1947 to 1962) with all sequences to 1958 (95% CI, 1949 to 1960) with the putative recombinants removed. Thus, intrasubtype recombinants are common within the subtype C epidemic and these impact analyses of HIV-1 evolution.

Entities:  

Mesh:

Year:  2007        PMID: 17314156      PMCID: PMC1900147          DOI: 10.1128/JVI.02050-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation.

Authors:  P P Rose; B T Korber
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Timing the ancestor of the HIV-1 pandemic strains.

Authors:  B Korber; M Muldoon; J Theiler; F Gao; R Gupta; A Lapedes; B H Hahn; S Wolinsky; T Bhattacharya
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

3.  Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents.

Authors:  C M Rodenburg; Y Li; S A Trask; Y Chen; J Decker; D L Robertson; M L Kalish; G M Shaw; S Allen; B H Hahn; F Gao
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

4.  Maximum likelihood estimation of recombination rates from population data.

Authors:  M K Kuhner; J Yamato; J Felsenstein
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

5.  Characterization of full-length HIV type 1 subtype C sequences from South Africa.

Authors:  J van Harmelen; C Williamson; B Kim; L Morris; J Carr; S S Karim; F McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  2001-11-01       Impact factor: 2.205

6.  Consequences of recombination on traditional phylogenetic analysis.

Authors:  M H Schierup; J Hein
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

Review 7.  Analyzing the mosaic structure of genes.

Authors:  J M Smith
Journal:  J Mol Evol       Date:  1992-02       Impact factor: 2.395

8.  High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Authors:  A E Jetzt; H Yu; G J Klarmann; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women.

Authors:  G Becker-Pergola; J L Mellquist; L Guay; F Mmiro; C Ndugwa; P Kataaha; J B Jackson; S H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2000-08-10       Impact factor: 2.205

10.  Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences.

Authors:  R Shankarappa; R Chatterjee; G H Learn; D Neogi; M Ding; P Roy; A Ghosh; L Kingsley; L Harrison; J I Mullins; P Gupta
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  34 in total

1.  Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.

Authors:  Binshan Shi; Christina Kitchen; Barbara Weiser; Douglas Mayers; Brian Foley; Kimdar Kemal; Kathryn Anastos; Marc Suchard; Monica Parker; Cheryl Brunner; Harold Burger
Journal:  Virology       Date:  2010-05-08       Impact factor: 3.616

2.  Clade-specific evolution mediated by HLA-B*57/5801 in human immunodeficiency virus type 1 clade A1 p24.

Authors:  Lyle R McKinnon; Rupert Capina; Harold Peters; Mark Mendoza; Joshua Kimani; Charles Wachihi; Anthony Kariri; Makobu Kimani; Meika Richmond; Sandy Koesters Kiazyk; Keith R Fowke; Walter Jaoko; Ma Luo; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

3.  An exploratory algorithm to identify intra-host recombinant viral sequences.

Authors:  Marco Salemi; Rebecca R Gray; Maureen M Goodenow
Journal:  Mol Phylogenet Evol       Date:  2008-08-31       Impact factor: 4.286

4.  Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors.

Authors:  Richard J P Brown; Paul J Peters; Catherine Caron; Maria Paz Gonzalez-Perez; Leanne Stones; Chiambah Ankghuambom; Kemebradikumo Pondei; C Patrick McClure; George Alemnji; Stephen Taylor; Paul M Sharp; Paul R Clapham; Jonathan K Ball
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering.

Authors:  Vlad Novitsky; Sikhulile Moyo; Quanhong Lei; Victor DeGruttola; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-06       Impact factor: 2.205

6.  Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015.

Authors:  Joris Hemelaar; Shanghavie Loganathan; Ramyiadarsini Elangovan; Jason Yun; Leslie Dickson-Tetteh; Shona Kirtley
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

7.  Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa.

Authors:  Edson Delatorre; Gonzalo Bello
Journal:  BMC Evol Biol       Date:  2016-11-16       Impact factor: 3.260

8.  HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk?

Authors:  Mary S Campbell; Geoffrey S Gottlieb; Stephen E Hawes; David C Nickle; Kim G Wong; Wenjie Deng; Thomas M Lampinen; Nancy B Kiviat; James I Mullins
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

9.  Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women.

Authors:  Alan R Templeton; Melissa G Kramer; Joseph Jarvis; Jeanne Kowalski; Stephen Gange; Michael F Schneider; Qiujia Shao; Guang Wen Zhang; Mei-Fen Yeh; Hua-Ling Tsai; Hong Zhang; Richard B Markham
Journal:  Retrovirology       Date:  2009-06-03       Impact factor: 4.602

10.  An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1.

Authors:  Sergei L Kosakovsky Pond; David Posada; Eric Stawiski; Colombe Chappey; Art F Y Poon; Gareth Hughes; Esther Fearnhill; Mike B Gravenor; Andrew J Leigh Brown; Simon D W Frost
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.